Growth Metrics

Ligand Pharmaceuticals (LGNDZ) Goodwill & Intangibles (2016 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Goodwill & Intangibles for 16 consecutive years, with $327.0 million as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles fell 12.08% to $327.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $327.0 million through Dec 2025, down 12.08% year-over-year, with the annual reading at $327.0 million for FY2025, 12.08% down from the prior year.
  • Goodwill & Intangibles hit $327.0 million in Q4 2025 for Ligand Pharmaceuticals, down from $335.1 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $774.3 million in Q1 2021 to a low of $303.3 million in Q4 2023.
  • Historically, Goodwill & Intangibles has averaged $464.2 million across 5 years, with a median of $384.3 million in 2024.
  • Biggest YoY gain for Goodwill & Intangibles was 157.36% in 2021; the steepest drop was 52.01% in 2021.
  • Year by year, Goodwill & Intangibles stood at $376.7 million in 2021, then dropped by 9.09% to $342.5 million in 2022, then fell by 11.43% to $303.3 million in 2023, then increased by 22.61% to $371.9 million in 2024, then dropped by 12.08% to $327.0 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for LGNDZ at $327.0 million in Q4 2025, $335.1 million in Q3 2025, and $351.7 million in Q2 2025.